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Absence status epilepticus (ASE) is a common form of nonconvulsive status 
epilepcticus. It is characterized by loss of consciousness with spike and wave 
discharges in EEG simultaneously. The most effective treatment of ASE is 
diazepam, either infusion or in divided doses; the former is more expensive 
since patients must be admitted in an Intensive Care Unit. The aim of this study 
was to evaluate and compare the efficacy of diazepam infusion and parenteral 
diazepam in divided doses in the treatment of ASE. 
Materials & Methods
This randomized controlled clinical trial, enrolled 20 patients with absence 
status epilepticus. Diagnosis was made based on the clinical manifestations and 
electroencephalogram (EEG). Prior to treatment, all patients underwent EEG and 
imaging. Patients were randomized to receive 0.2 mg/kg/h diazepam infusion or 
0.2 mg/kg in six daily doses. Clinical and EEG improvements were considered 
to be optimal responses.
Results
Of the 20 patients studied, 13 (65%) were boys and the remaining 7(35%) were 
girls. There were no differences between the two groups regarding age and 
sex (non-significant). Following treatments after 48 hours, 1 week and 1 month 
respectively, clinical improvement in previous problems  (loss of consciousness, 
ataxia, behavior and speech problems) and EEGs was similar in both groups 
(p=1). There were controlled seizures in 18 (90%), abnormal CT scans in 5 
(25%), abnormal EEGs after treatments in 6 (30%) cases; however no significant 
differences were seen between the two groups.
Conclusion
This study demonstrates that there are no significant differences between 
treatments of ASE with diazepam infusion and parenteral diazepam in divided 
doses. Treatment of ASE, with divided doses of diazepam is easier, less expensive 
and patients do not require to be hospitalized in an Intensive Care unit.
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Introduction
Absence Status Epilepticus  (ASE), a prolonged absence seizure, first described 
clinically and electrographically by Putaman and Lenox (1,2),  is one subtype of 
nonconvulsive status epilepticus. The term was first proposed by the commission 
on classification and terminology of the International League Against Epilepsy (3, 
4). Some synonyms are petit mal status, spike-and-wave stupor, and minor epileptic 
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status. The frequency of ASE ranges from 5% to 10% 
among patients with primary generalized epilepsy, being 
3% in patients with absence seizures. In 75% of cases 
ASE occurs before the age of 20 years (5,6).
Absence status is divided to typical and atypical forms. In 
both forms, there is a paroxysmal loss of consciousness 
clinically associated with bursts of bilaterally synchronous 
spike-and-wave discharges on the EEG (5). The main 
distinction of atypical absence status is that it occurs 
mainly in children with symptomatic or cryptogenic 
generalized epilepsies. In addition, the interictal EEG 
is abnormal, with most of these patients also having 
moderate to severe learning and physical handicaps (6,7). 
Outcomes of ASE are related more to type and cause of 
the underlying epilepsy; it may occur only once in a life 
time or may be frequent and intractable in patients with 
symptomatic generalized epilepsies (6). Benzodiazepins, 
such as clonazepam, lorazepam or diazepam, that may 
be administrated orally or parenterally, are the drugs of 
choice for the treatment of absence status (6-9), and can 
be repeated every 3 to 4 hours (5). However ASE may 
recur (10,11). The aim of this study was to compare the 
efficacy of using diazepam either by its infusion or in 
divided parenteral doses in the treatment of ASE. 
Materials & Methods
Between 2006 and 2007, twenty patients, aged between 
1 and 14 years were enrolled in the Mofid children’s 
hospital, Tehran, for this randomized controlled clinical 
trial. Diagnosis was based on clinical manifestations and 
electroencephalograms. We conducted this randomized 
study to compare using diazepam infusion and divided 
doses diazepam as first line treatment for ASE. Patients 
were selected randomly two groups-one treated with 
diazepam infusion and the other with divided doses 
diazepam-and sufficiently matched. All patients 
underwent EEGs prior to and 48 hours following 
treatments. Patients were randomized into two groups, 
the first receiving parenteral diazepam (0.2 mg/kg/hour), 
following hospitalization in ICU. The second group 
was hospitalized at the neurology ward and received 
diazepam parenterally 0.2 mg/kg in six daily doses. If, 
after 48 hours, there no clinical or EEG improvement 
were observed, therapy was discontinued. Basic work up 
included CBC (diff), BS (blood sugar), and UA (urine 
analysis), EEG, and imaging.
 
Results
Of the twenty patients studied, 13 (65%) were boys and 
7 (35%) were girls. There were no differences between 
the two groups regarding sex and age. (p>0.05) (table1)
Before treatments, all patients had continuous spike and 
wave discharges in their tracings. Of twenty children, 
18 (90%) had previous seizures, partial or generalized, 
which were controlled. Imaging (CT scan and MRI) 
was abnormal in 5 (25%) patients due to mild cortical 
atrophy (table 1). Major clinical manifestations at the 
time of admission, were lethargy in 14 (70%), ataxia in 
10 (50%). Speech and behavior problems were found in 
7 (35%) patients. There were no significant differences 
between the two groups (P > 0.05).
After the end of 48 hours of therapy, EEGs were done; 
of the twenty patients, 14 (70%) had normal EEG and 
6 (30%) had mild abnormalities in their EEGs, without 
spike and wave discharges, indicating no significant 
differences between two groups (P > 0.05) (Table2).
Clinical manifestations for patients were assessed after 
48 hours, 3-7 days and at   One week and one month. 
In 5 (25%) patients, lethargy improved after 48 hours 
and in 9 (45%) after 3-7 days. Ataxia was found to have 
improved in 6 (30%) patients after 3-7 days, while in 4 
(20%) patients the improvement was observed around 
1 week to 1 month later. Speech and behavior problems 
in 4(20%) improved after 3-7 days, and between 1 week 
and 1 month in 3 (15%) cases. No side effects occurred 
during therapy.
Discussion
Treatment of absence status epilepticus (ASE) may be 
accomplished with either oral or parenteral antiepileptic 
drug therapy (5). Benzodiazepins are the drugs of choice, 
with the intravenous route being preferred usually if 
emergency facilities are available. Both typical absence 
status and late onset absence status respond to intravenous 
diazepam 0.2-0.3 mg/kg, clonazepam 1 mg/kg (0.5 mg 
in children) or lorazepam 0.1mg/kg (3, 5,6, 11), doses 
which can be repeated every 2 to 4 hours. If control is 
not easily achieved, i.v. valproate may be successful (3, 
13) and sometimes rectal diazepam or buccal midazolam 
have also been effective (6,11). Some drugs such as 
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phenyton, carbamazipin, vigabatrin, and tiagabine may 
induce refractory ASE (6, 12). In a study four of five 
children in ASE responded rapidly after a single loading 
dose of 20-40 mg/kg i.v. valproate without significant 
side effects (13). 
In our study, no significant differences were seen in 
response to treatments, between two groups. There were 
no side effects or recurrence in either group. we did not 
find any similar study as ours.
In conclusion, this study demonstrates that despite 
diazepam being effective in the treatment of ASE, 
diazepam, in divided doses, is recommended, since 
it is less expensive and the patients do not need to be 
hospitalized in the ICU.
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P = 1 (T-test) non-significant8.35±4.608.35±3.44(mean ±SD)Age (year)
P = 0.474 (fisher test)
8 (80%)10 (100%)controlledPrevious 
convulsion 2 (20%)0uncontrolled





 * DI: Diazepam Infusion
** DD: Divided doses diazepam
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P = 1 (Fisher test)
 non-significant
1 (10%)4 (40%)6 (60%)DI (n=10)
3-7 days




1 (10%)3 (30%)—DI (n=10
After 1 week 
2 (20%)1 (10%)—DD (n=10)
* DI: Diazepam Infusion
** DD: Divided doses diazepam
*** improvement
Table 3: EEG status in the DI and DD groups after 48 h treatment
EEG
AbnormalNormal
3 (30%)7 (70%)DI* (n = 10)
3 (30%)7 (70%)DD** (n = 10)
* DI: Diazepam Infusion
** DD: Divided doses diazepam
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